Atlas Biolabs

Atlas Biolabs is an established, revenue-generating service provider in the genomics and proteomics space, offering advanced analytical and bioinformatics services to research clients. The company leverages state-of-the-art technologies like NGS and microarrays to support projects in areas such as oncology, pharmacogenetics, microbiome research, and precision medicine. With a strong focus on quality and experience in managing third-party-funded projects, it positions itself as a reliable partner for complex genetic analyses. Its business model is purely service-based, with no internal therapeutic or diagnostic product development pipeline.

Integrated service platform combining wet-lab technologies (NGS, microarrays, proteomics, microbiome sequencing) with a full-suite bioinformatics and data analysis division for end-to-end project support.

Atlas Biolabs competes in a crowded field of genomic service providers, ranging from global giants like Eurofins Genomics and Novogene to numerous regional and specialty CROs. Its differentiation is based on a combined wet-lab and bioinformatics offering, a focus on complex projects, and a strong regional presence in the German/European research ecosystem. The addition of proteomics helps differentiate its multi-omics capability.